Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation
- 5 June 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 38 (2), 149-156
- https://doi.org/10.1038/sj.bmt.1705410
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Cytokine profiles in stem cell transplantation: Possible use as a predictor of graft-versus-host diseaseHematology, 2005
- Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factorBlood, 2003
- Recent advances in allogeneic hematopoietic stem-cell transplantationJournal of Laboratory and Clinical Medicine, 2003
- The Crystal Structure of Human Placenta Growth Factor-1 (PlGF-1), an Angiogenic Protein, at 2.0 Å ResolutionOnline Journal of Public Health Informatics, 2001
- Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndromeBone Marrow Transplantation, 2000
- Opportunistic infections after blood and marrow transplantationTransplant Infectious Disease, 1999
- Relative Contribution of Endothelial Cell and Polymorphonuclear Neutrophil Activation in Their Interactions in Systemic Inflammatory Response SyndromeArchives of Surgery, 1996
- Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue.The Journal of Experimental Medicine, 1994
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992
- Regulators of AngiogenesisAnnual Review of Physiology, 1991